Fig. 7From: Docking and dynamic simulation study of Crizotinib and Temozolomide drug with Glioblastoma and NSCLC target to identify better efficacy of the drugRMSF graph based on ligand-free protein and ligand bounded protein complex of C-ROS1 proteinBack to article page